| abstract |
REFERRING TO PRODRUG COMPOUNDS OF FORMULA I WHERE X IS C, N; W IS C, N; V IS C; R1 H, METHOXY, HALOGEN; R2 IS H; R3 IS METHOXY, HETEROARYL; E IS H, MONO OR BIS TYPE SALT; AND IS (a), (b); R10, R11, R13, R14, R15, R16 AND R17 ARE EACH H, METHYL; R18 C (O) -PHENYL, C (O) -PYRIDINYL, QUINAZOLYL, AMONG OTHERS; D IS CYANE, HALOGEN, PHENYL, AMONG OTHERS; A IS PHENYLUS, FURILE, TIENYL, AMONG OTHERS. ALSO CONCERNING A PROCEDURE FOR THE PREPARATION OF THESE COMPOUNDS AND THEIR INTERMEDIARIES WHOSE PREFERRED INTERMEDIARIES ARE: {3 - [(4-BENZOPIPERAZIN-1-IL) (OXO) ACETYL] -4,7-DIMETOXY-1H-PIRROLO PHOSPHATE [2,3-c] PYRIDIN-1-IL} METHYL; [3 - [(4-BENZOPIPERAZIN-1-IL) (OXO) ACETYL] -4-FLUORO-7- (1H-1,2,3-TRIAZOL-1-IL) -1H-PYRROLE (2, 3-c] PYRIDIN-1-IL] METHYL, AMONG OTHERS, SUCH COMPOUNDS ARE USEFUL IN THE TREATMENT OF HIV INFECTIONS |